 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol IDs
|
|
|
| |
Cisplatin and Radiation Therapy With or Without Hyperthermia Therapy in Treating Patients With Cervical Cancer
|
|
|
|
Phase III
|
|
|
|
DUMC-4516-04-2R1ER
DUMC-G030263, DUMC-4516031R0, NCT00085631
|
|
| |
Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
|
|
|
|
Phase III
|
|
|
|
GOG-0219
GOG-0219, CAN-NCIC-GOG-0219, NCT00262821
|
|
| |
Weekly IV Topotecan and Cisplatin With Radiation in Cervical Carcinoma
|
|
|
|
Phase II
|
|
|
|
UCI 03-33
NCT00257816
|
|
| |
Cetuximab, Cisplatin, and Radiotherapy in Women With Locally Advanced Cervical Carcinoma
|
|
|
|
Phase II
|
|
|
|
05-0702
CA225243, NCT00292955
|
|
| |
Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery
|
|
|
|
Phase II
|
|
|
|
RTOG-0418
RTOG-0418, NCT00331760
|
|
| |
Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancer
|
|
|
|
Phase II
|
|
|
|
RTOG-0417
RTOG-0417, NCT00369122
|
|
| |
Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
|
|
|
|
Phase II
|
|
|
|
CINJ-3330
NCT00161187
|
|
| |
Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix Cancer
|
|
|
|
Phase II
|
|
|
|
AVF3963s
NCT00600210
|
|
| |
Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer
|
|
|
|
Phase I
|
|
|
|
GOG-9913
NCT00054444, GOG-9913
|
|
| |
Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer
|
|
|
|
Phase I
|
|
|
|
GOG-9918
GOG-9918, NCT00104910
|
|
